COPD in the Time of COVID-19
Cross-Sectional Observation Telephone Survey Study to Understand the Changes in COPD Exacerbation Patterns and Potential Causes of These During the COVID-19 Pandemic
1 other identifier
observational
160
1 country
1
Brief Summary
This cross-sectional observational study will collect information about changes in exacerbation frequency and behaviour amongst a clinical cohort of severe or complex COPD clinic patients. This will be done through a combination of telephone survey and access to electronic heath records.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 27, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedNovember 3, 2020
May 1, 2020
1 month
May 27, 2020
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in COPD Exacerbation Rate
The primary outcome will be the change in number of moderate or severe AECOPD events over the 46 days from the 15th March, 2020 to 30th April, 2020 compared to the same 46 day period in 2019.
46 days
Secondary Outcomes (13)
Change in number of Severe AECOPD events during period of interest in 2020 from same period in 2019.
46 days
Change in Moderate AECOPD events during period of interest in 2020 from same period in 2019.
46 days
Social contact changes during i) pre-lockdown and ii) lockdown period
46 days
Household contacts during i) pre-lockdown and ii) lockdown period
46 days
Household visitors during i) pre-lockdown and ii) lockdown period
46 days
- +8 more secondary outcomes
Study Arms (1)
Glenfield Complex COPD Clinic Cohort
Patients previously seen in the complex COPD clinic at the Glenfield Hospital.
Eligibility Criteria
Patients known to have COPD and previously seen in the Complex COPD Clinic at the Glenfield Hospital, Leicester.
You may qualify if:
- Confirmed clinical diagnosis of COPD
- Ability to provide informed verbal consent via English language telephone consultation
- Adults aged over 40 years
You may not qualify if:
- Patients currently admitted to hospital
- Unwilling/unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- University Hospitals, Leicestercollaborator
Study Sites (1)
NIHR Leicester Biomedical Research Centre (Respiratory), Glenfield Hospital
Leicester, LE3 9QG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil J Greening, PhD
University of Leicester
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2020
First Posted
May 29, 2020
Study Start
May 1, 2020
Primary Completion
June 8, 2020
Study Completion
June 1, 2021
Last Updated
November 3, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share